Overexpression of the Endothelial Protein C Receptor Is Detrimental during Pneumonia-Derived Gram-negative Sepsis (Melioidosis)

PLoS Neglected Tropical Diseases

Volumn 7, Issue 7, 2013, Pages

  Kager, Liesbeth M ^a   Schouten, Marcel ^a   Wiersinga, W Joost ^a   de Boer, J Daan ^a   Lattenist, Lionel C W ^a   Roelofs, Joris J T H ^a   Meijers, Joost C M ^a   Levi, Marcel ^a   Dondorp, Arjen M ^b,c   Esmon, Charles T ^d   van 't Veer, Cornelis ^a   van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAHIDOL UNIVERSITY   (Thailand)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL PROTEIN C RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BLOOD CLOTTING; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LUNG INJURY; MALE; MELIOIDOSIS; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; UPREGULATION;

EID: 84880824585     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002306     Document Type: Article

References (54)

1. Currie BJ, Ward L, Cheng AC, (2010) The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year darwin prospective study. PLoS Negl Trop Dis 4: e900 10.1371/journal.pntd.0000900 [doi].
2. Cheng AC, Currie BJ, (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383-416 18/2/383 [pii];10.1128/CMR.18.2.383-416.2005 [doi].
3. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ, (2006) Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 4: 272-282 nrmicro1385 [pii];10.1038/nrmicro1385 [doi].
4. Wiersinga WJ, Currie BJ, Peacock SJ, (2012) Melioidosis. N Engl J Med 367: 1035-1044 10.1056/NEJMra1204699 [doi].
5. White NJ, (2003) Melioidosis. Lancet 361: 1715-1722 S0140673603133740 [pii].
6. Butler D, (2012) Viral research faces clampdown. Nature 490: 456 490456a [pii];10.1038/490456a [doi].
7. Levi M, van der Poll T, (2010) Inflammation and coagulation. Crit Care Med 38: S26-S34 10.1097/CCM.0b013e3181c98d21 [doi].
8. Delvaeye M, Conway EM, (2009) Coagulation and innate immune responses: can we view them separately? Blood 114: 2367-2374 blood-2009-05-199208 [pii];10.1182/blood-2009-05-199208 [doi].
9. Mosnier LO, Zlokovic BV, Griffin JH, (2007) The cytoprotective protein C pathway. Blood 109: 3161-3172 blood-2006-09-003004 [pii];10.1182/blood-2006-09-003004 [doi].
10. Esmon CT, (2003) The protein C pathway. Chest 124: 26S-32S.
11. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT, (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A 93: 10212-10216.
12. Esmon CT, (2006) The endothelial protein C receptor. Curr Opin Hematol 13: 382-385 10.1097/01.moh.0000239712.93662.35 [doi];00062752-200609000-00014 [pii].
13. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV, (2007) Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 282: 11849-11857 M609283200 [pii];10.1074/jbc.M609283200 [doi].
14. Preston RJ, Ajzner E, Razzari C, Karageorgi S, Dua S, et al. (2006) Multifunctional specificity of the protein C/activated protein C Gla domain. J Biol Chem 281: 28850-28857 M604966200 [pii]; doi:[] 10.1074/jbc.M604966200 [doi].
15. Sen P, Gopalakrishnan R, Kothari H, Keshava S, Clark CA, et al. (2011) Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection. Blood 117: 3199-3208 blood-2010-09-310706 [pii];10.1182/blood-2010-09-310706 [doi].
16. Lattenist L, Kers J, Ten Berge IJ, Florquin S, Roelofs JJ, (2011) Renal and urinary levels of EPCR correlate with acute renal allograft rejection. J Thromb Haemost 9: 706.
17. Gleeson EM, O'Donnell JS, Preston RJ, (2011) The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling. Cell Mol Life Sci 69: 717-726 10.1007/s00018-011-0825-0 [doi].
18. Kurosawa S, Stearns-Kurosawa DJ, Hidari N, Esmon CT, (1997) Identification of functional endothelial protein C receptor in human plasma. J Clin Invest 100: 411-418 10.1172/JCI119548 [doi].
19. Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR, et al. (1996) The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 271: 17491-17498.
20. Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT, (2001) Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97: 1685-1688.
21. Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, et al. (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95: 1680-1686.
22. Zheng X, Li W, Song Y, Hu Y, Ferrell GL, et al. (2007) Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia. J Thromb Haemost 5: 1394-1400 JTH02592 [pii];10.1111/j.1538-7836.2007.02592.x [doi].
23. Li W, Zheng X, Gu J, Hunter J, Ferrell GL, et al. (2005) Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost 3: 1351-1359 JTH1385 [pii];10.1111/j.1538-7836.2005.01385.x [doi].
24. Kerschen E, Hernandez I, Zogg M, Jia S, Hessner MJ, et al. (2010) Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest 120: 3167-3178 42629 [pii];10.1172/JCI42629 [doi].
25. Liaw PC, Esmon CT, Kahnamoui K, Schmidt S, Kahnamoui S, et al. (2004) Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 104: 3958-3964 10.1182/blood-2004-03-1203 [doi];2004-03-1203 [pii].
26. Kurosawa S, Stearns-Kurosawa DJ, Carson CW, D'Angelo A, Della VP, et al. (1998) Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91: 725-727.
27. Guitton C, Gerard N, Sebille V, Bretonniere C, Zambon O, et al. (2011) Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis. Intensive Care Med 37: 950-956 10.1007/s00134-011-2171-y [doi].
28. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, et al. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345: 408-416 10.1056/NEJM200108093450603 [doi].
29. Borgel D, Bornstain C, Reitsma PH, Lerolle N, Gandrille S, et al. (2007) A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am J Respir Crit Care Med 176: 878-885 200611-1692OC [pii];10.1164/rccm.200611-1692OC [doi].
30. Wiersinga WJ, Meijers JC, Levi M, van 't Veer C, Day NP, et al. (2008) Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis. J Thromb Haemost 6: 32-39 JTH2796 [pii];10.1111/j.1538-7836.2007.02796.x [doi].
31. LaRosa SP, Opal SM, Utterback B, Yan SC, Helterbrand J, et al. (2006) Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei. Int J Infect Dis 10: 25-31 S1201-9712(05)00140-2 [pii];10.1016/j.ijid.2005.06.001 [doi].
32. Koh GC, Meijers JC, Maude RR, Limmathurotsakul D, Day NP, et al. (2011) Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis). Thromb Haemost 106: 1139-1148 11-07-0504 [pii];10.1160/TH11-07-0504 [doi].
33. Kager LM, Wiersinga WJ, Roelofs JJ, Meijers JC, Levi M, et al. (2011) Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis (melioidosis). J Thromb Haemost 9: 2020-2028 10.1111/j.1538-7836.2011.04473.x [doi].
34. Kager LM, Wiersinga WJ, Roelofs JJ, Meijers JC, Levi M, et al. (2012) Endogenous tissue-type plasminogen activator impairs host defense during severe experimental gram-negative sepsis (melioidosis). Crit Care Med 40: 2168-2175 10.1097/CCM.0b013e31824ea05e [doi].
35. Wiersinga WJ, Wieland CW, Dessing MC, Chantratita N, Cheng AC, et al. (2007) Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med 4: e248 06-PLME-RA-0761 [pii];10.1371/journal.pmed.0040248 [doi].
36. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256 10.1097/01.CCM.0000050454.01978.3B [doi].
37. Li W, Zheng X, Gu JM, Ferrell GL, Brady M, et al. (2005) Extraembryonic expression of EPCR is essential for embryonic viability. Blood 106: 2716-2722 2005-01-0406 [pii];10.1182/blood-2005-01-0406 [doi].
38. Gu JM, Katsuura Y, Ferrell GL, Grammas P, Esmon CT, (2000) Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood 95: 1687-1693.
39. Crawley JT, Gu JM, Ferrell G, Esmon CT, (2002) Distribution of endothelial cell protein C/activated protein C receptor (EPCR) during mouse embryo development. Thromb Haemost 88: 259-266.
40. Lauw FN, Simpson AJ, Prins JM, Smith MD, Kurimoto M, et al. (1999) Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis 180: 1878-1885 JID990606 [pii];10.1086/315155 [doi].
41. Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, et al. (2004) A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 103: 1311-1318 10.1182/blood-2003-07-2520 [doi];2003-07-2520 [pii].
42. Conway EM, Rosenberg RD, (1988) Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 8: 5588-5592.
43. Moore KL, Esmon CT, Esmon NL, (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73: 159-165.
44. Fukudome K, Esmon CT, (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269: 26486-26491.
45. Archipoff G, Beretz A, Freyssinet JM, Klein-Soyer C, Brisson C, et al. (1991) Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 273 (Pt 3):: 679-684.
46. Xu J, Qu D, Esmon NL, Esmon CT, (2000) Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem 275: 6038-6044.
47. Hataji O, Taguchi O, Gabazza EC, Yuda H, Fujimoto H, et al. (2002) Activation of protein C pathway in the airways. Lung 180: 47-59 10.1007/s004080000080 [doi].
48. Shimizu S, Gabazza EC, Taguchi O, Yasui H, Taguchi Y, et al. (2003) Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med 167: 1416-1426 10.1164/rccm.200206-515OC [doi];167/10/1416 [pii].
49. Finigan JH, Boueiz A, Wilkinson E, Damico R, Skirball J, et al. (2009) Activated protein C protects against ventilator-induced pulmonary capillary leak. Am J Physiol Lung Cell Mol Physiol 296: L1002-L1011 90555.2008 [pii];10.1152/ajplung.90555.2008 [doi].
50. Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, et al. (2007) Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13: 1349-1358 nm1667 [pii];10.1038/nm1667 [doi].
51. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, et al. (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-3512 1222878110 [pii];10.1073/pnas.1222878110 [doi].
52. Simpson AJ, Smith MD, Weverling GJ, Suputtamongkol Y, Angus BJ, et al. (2000) Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. J Infect Dis 181: 621-625 JID990893 [pii];10.1086/315271 [doi].
53. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ, (1999) Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 67: 3593-3600.
54. Iwaki T, Cruz DT, Martin JA, Castellino FJ, (2005) A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse. Blood 105: 2364-2371 2004-06-2456 [pii];10.1182/blood-2004-06-2456 [doi].